We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$15.1B
AUM Growth
-$1.32B
(-8.1%)
Cap. Flow
-$1.84B
Cap. Flow
% of AUM
-12.19%
Top 10 Holdings %
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$66.7M |
| 2 |
MSCI
MSCI
|
+$54.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$46.5M |
| 4 |
ResMed
RMD
|
+$44.7M |
| 5 |
PPG Industries
PPG
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$74M |
| 2 |
L3Harris
LHX
|
+$69.6M |
| 3 |
Honeywell
HON
|
+$64.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$60.2M |
| 5 |
Wells Fargo
WFC
|
+$59.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.88% |
| 2 | Consumer Discretionary | 8.49% |
| 3 | Financials | 8.33% |
| 4 | Industrials | 8.18% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$435B
| $18.1M | 0.12% |
+134,178
| New | +$19.7M |
|
152
Lear
LEA
$6.18B
| $18.1M | 0.12% |
125,913
+21,183
| +20% | +$2.8M |
|
153
Manhattan Associates
MANH
$11.2B
| $18M | 0.12% |
89,985
-29,462
| -25% | -$5.12M |
|
154
CALL
Merck
MRK
$317B
| $17.9M | 0.12% |
155,500
-39,200
| -20% | -$4.45M |
|
155
CALL
US Bancorp
USB
$100B
| $17.9M | 0.12% |
542,400
+495,200
| +1,049% | +$16M |
|
156
CSX Corp
CSX
$94.7B
| $17.9M | 0.12% |
523,876
-333,378
| -39% | -$10.5M |
|
157
Zoom
ZM
$29.5B
| $17.8M | 0.12% |
262,512
+39,387
| +18% | +$2.63M |
|
158
Inspire Medical Systems
INSP
$1.73B
| $17.8M | 0.12% |
54,844
-73,113
| -57% | -$20.9M |
|
159
CALL
Goldman Sachs
GS
$313B
| $17.7M | 0.12% |
55,000
+32,400
| +143% | +$10.7M |
|
160
CALL
Verizon
VZ
$193B
| $17.7M | 0.12% |
476,300
-94,400
| -17% | -$3.49M |
|
161
Erie Indemnity
ERIE
$13.1B
| $17.6M | 0.12% |
+83,881
| New | +$18.7M |
|
162
Motorola Solutions
MSI
$72.7B
| $17.5M | 0.12% |
59,685
+15,652
| +36% | +$4.48M |
|
|
163
CALL
Alphabet (Google) Class A
GOOGL
$4.43T
| $17.5M | 0.12% |
146,100
-22,700
| -13% | -$2.61M |
|
164
Duolingo
DUOL
$6.3B
| $17.3M | 0.12% |
121,312
+95,926
| +378% | +$13.7M |
|
165
BioMarin Pharmaceuticals
BMRN
$11.6B
| $17.3M | 0.12% |
199,927
+171,674
| +608% | +$16.2M |
|
166
Dell
DELL
$299B
| $17.3M | 0.11% |
319,461
+236,834
| +287% | +$10.9M |
|
167
Xcel Energy
XEL
$48.2B
| $17.1M | 0.11% |
275,463
+94,088
| +52% | +$6.28M |
|
168
Nasdaq
NDAQ
$52.9B
| $17.1M | 0.11% |
342,157
+206,119
| +152% | +$11.2M |
|
169
Etsy
ETSY
$8.15B
| $17M | 0.11% |
200,707
+117,081
| +140% | +$11M |
|
170
CALL
MetLife
MET
$61.9B
| $16.9M | 0.11% |
299,400
+273,700
| +1,065% | +$15.2M |
|
171
CVS Health
CVS
$126B
| $16.9M | 0.11% |
244,653
-747,673
| -75% | -$53.2M |
|
172
CALL
Procter & Gamble
PG
$342B
| $16.9M | 0.11% |
111,100
-700
| -0.6% | -$106K |
|
|
WRK
173
DELISTED
WestRock Company
WRK
| $16.8M | 0.11% |
579,484
+557,461
| +2,531% | +$16.2M |
|
|
174
PUT
Procter & Gamble
PG
$342B
| $16.8M | 0.11% |
111,000
-70,800
| -39% | -$10.7M |
|
175
KBR
KBR
$4.58B
| $16.8M | 0.11% |
258,860
+203,333
| +366% | +$12.1M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.
- Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
- Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
- Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
- Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
- Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
- Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
- Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.